Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$165.13 - $241.83 $217,311 - $318,248
-1,316 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$163.99 - $235.57 $110,037 - $158,067
-671 Reduced 33.77%
1,316 $271,000
Q2 2021

Aug 16, 2021

SELL
$131.45 - $201.49 $7,361 - $11,283
-56 Reduced 2.74%
1,987 $377,000
Q1 2021

May 17, 2021

SELL
$92.73 - $142.05 $296,365 - $453,991
-3,196 Reduced 61.0%
2,043 $266,000
Q4 2020

Feb 16, 2021

BUY
$67.44 - $103.72 $270,029 - $415,294
4,004 Added 324.21%
5,239 $543,000
Q3 2020

Nov 16, 2020

BUY
$42.79 - $75.8 $52,845 - $93,613
1,235 New
1,235 $94,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.